SCHEMBL6783486

SCHEMBL6783486

CC(CN(C)C(=O)CCC(N)=O)c1ccc(-c2ccsc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 2/20 0.45
ALOX5 P09917 1/20 0.36
CHEK2 O96017 3/20 0.36
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
GPR88 Q9GZN0 1/20 0.35
CYP17A1 P05093 2/20 0.35
CHEK1 O14757 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
P2RX3 P56373 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6787367 0.89 GRIA4 (0.49) GRIA4ALOX5CHEK2CTSLCTSB
SCHEMBL6793943 0.73 GRIA4 (0.51) GRIA4CHEK2CTSLCTSBCTSS
SCHEMBL6783058 0.73 GRIA4 (0.51) GRIA4ALOX5CHEK2CTSLCTSB
SCHEMBL6783013 0.73 GRIA4 (0.59) GRIA4CHEK2CTSLCTSBCTSS
SCHEMBL6783488 0.71 GRIA4 (0.54) GRIA4ALOX5CHEK2CTSLCTSB
SCHEMBL6789299 0.71 GRIA4 (0.44) GRIA4ALOX5CTSLCTSBCTSS
SCHEMBL6795078 0.71 GRIA4 (0.56) GRIA4CTSLCTSBCTSSCTSK
SCHEMBL6787374 0.71 GRIA4 (0.56) GRIA4ALOX5CHEK2CTSLCTSB
SCHEMBL6783719 0.70 GRIA4 (0.63) GRIA4CTSLCTSBCTSSCTSK
SCHEMBL4584209 0.70 GRIA4 (0.63) GRIA4CTSLCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097499-A1 Amide, carbamate, and urea derivatives ARNOLD MACKLIN BRIAN (US) 2004-05-20 US disclosed
US-6617351-B1 Amide, carbamate, and urea derivatives ELI LILLY AND COMPANY 2003-09-09 US disclosed
WO-2000006156-A1 AMIDE, CARBAMATE, AND UREA DERIVATIVES ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976744-A1 Amide, carbamate, and urea derivatives having glutamate receptor function potentiating activity ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097499-A1 Amide, carbamate, and urea derivatives GRIN2A, GLUL, GRIK5 GRIA4 16/4885ALOX5 3689/4885CHEK2 2244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.